BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Neurophth Begins Phase I/II Trial for Second Gene Therapy with First Patient Dosed

Neurophth is conducting a Phase I/II, multi-region, multi-center, single-arm, open-labeled, dose-finding study aimed at evaluating the safety, tole...

August 18, 2023 | News

MGI Unveils Latest MGISP-NEX and MGIFLP-L50 Automation Systems

MGI, a company committed to building core tools and technology to lead life science, today announced the global launch of MGISP-NEX and MGIFLP-L50 automati...

August 17, 2023 | News

CytoMed Collaborates for Improved Allogeneic CAR γδ T In Vivo Persistence in China

CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its propr...

August 16, 2023 | News

OnCusp Therapeutics Gets FDA Nod for Phase 1 Trial of CUSP06 in Ovarian & Solid Tumors

"We are delighted to announce the IND approval for our flagship program, CUSP06, which has demonstrated excellent anti-tumor efficacy across diverse in&nbs...

August 16, 2023 | News

Thermo Fisher Scientific Completes Acquisition of CorEvitas

Advances World-Class Clinical Research Capabilities with Leading Regulatory-Grade Registries Platform Expected to Be Accretive to Adjusted Earnings Per Sh...

August 15, 2023 | News

HebeCell & Logomix Partner for Next Gen PSC-NK Cell Development

Under the agreement, the companies enter a strategic partnership where Logomix first provides genome editing capabilities to HebeCell for development of ne...

August 15, 2023 | News

Neurophth Raises Almost $95M for Gene Therapy Trials in Series C+ Funding

Additionally, several prominent investment firms participated, including CMG-SDIC Capital, Silicon Paradise Asset Management and Yangtze River Industry Fun...

August 14, 2023 | News

WuXi Biologics and Boostimmune Sign MOU for Exclusive Research and Discovery Services

Under the collaboration, Boostimmune will have access to WuXi Biologics' integrated discovery services and extensive expertise in antibody discovery, lead ...

August 11, 2023 | News

Clarity's theranostic prostate cancer trial advances to highest dose level

Highlights Cohort 2 of the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) ha...

August 11, 2023 | News

Aichi Cancer Center & NEC Advance Lung Cancer Antigen Identification

Aichi Cancer Center and NEC developed a method for efficiently identifying lung cancer antigens (oncology marks) and antigen-specific T cells by comb...

August 10, 2023 | News

Next-Level Biologics Manufacturing: Lonza Launches TheraPRO® CHO Media System to Drive Protein Production Efficiency

Lonza has recently launched a new cell culture platform — the TheraPRO® CHO Media System. Can you tell us more about it? What are the key...

August 07, 2023 | Influencers

JinMed's Nanobathing Products Earn Patents, Secure Procurement Deal with Shanghai Zhongjin HongKang Medical Technology

Currently, the Company's nanobathing products have been granted an invention patent and four utility model patents. Among them, one medical nanobathing car...

August 04, 2023 | News

MANA Develops Novel "Drycell" Microdroplets to Make Handling Single Cell Easier

To analyze individual cells, the desired number of cells must be isolated spatially. This often requires extensive training and use of expensive laboratory...

August 04, 2023 | News

Cicada Innovations Expands to Westmead Health & Innovation District with Investment NSW Support

The incubator will be the first health-focused incubator funded by the NSW government to support pre-revenue health-tech startups in bridging the gap betwe...

August 04, 2023 | News

Stay Connected